Trial Profile
A randomised phase II trial of ME 143 in combination with standard-of-care chemotherapy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2011
Price :
$35
*
At a glance
- Drugs ME 143 (Primary) ; Antineoplastics
- Indications Solid tumours
- Focus Therapeutic Use
- 12 Sep 2011 New trial record